| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/(SICI)1096-8628(19980106)75:1<62::AID-AJMG14>3.0.CO;2-Q |
| P698 | PubMed publication ID | 9450860 |
| P50 | author | Aad Tibben | Q40608078 |
| P2093 | author name string | Duivenvoorden HJ | |
| Niermeijer MF | |||
| Passchier J | |||
| Trijsburg RW | |||
| DudokdeWit AC | |||
| P2860 | cites work | Suicide risk in Huntington's disease | Q22306512 |
| A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 | ||
| The hospital anxiety and depression scale | Q27860968 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| Identification of FAP locus genes from chromosome 5q21 | Q28300247 | ||
| Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation | Q28307938 | ||
| Attachment in Late Adolescence: Working Models, Affect Regulation, and Representations of Self and Others | Q29038080 | ||
| Identification and characterization of the familial adenomatous polyposis coli gene | Q29620382 | ||
| Duration of illness in Huntington's disease is not related to age at onset | Q33590479 | ||
| Predictive testing for Huntington's disease: after the gene. The United Kingdom Huntington's Disease Prediction Consortium | Q33596115 | ||
| Age at onset in Huntington's disease: effect of line of inheritance and patient's sex. | Q33597329 | ||
| Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making | Q33677759 | ||
| Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup. | Q33678811 | ||
| Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. | Q33968674 | ||
| Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. | Q34334383 | ||
| The illusion of mental health | Q34346279 | ||
| Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program | Q39480531 | ||
| Psychological costs and benefits of predictive testing for Huntington's disease | Q39481562 | ||
| On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program | Q39492418 | ||
| Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program | Q39494100 | ||
| Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk | Q41123560 | ||
| Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates | Q41244846 | ||
| Social system responses to Huntington disease | Q44306361 | ||
| The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing | Q44363828 | ||
| The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale | Q44759147 | ||
| Self-selection in predictive testing for Huntington's disease | Q45288684 | ||
| Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk | Q45292147 | ||
| Few psychological consequences of presymptomatic testing for Huntington disease | Q45293652 | ||
| Testing for Huntington's disease with support for all parties | Q45293838 | ||
| Psychological consequences of presymptomatic testing for Huntington's disease | Q45293939 | ||
| Exploration of the effects of predictive testing for Huntington disease on intimate relationships | Q45307535 | ||
| Clinical predictors of eventual suicide: a 5- to 10-year prospective study of suicide attempters | Q47355265 | ||
| Knowledge of the adenomatous polyposis coli gene and its clinical application. | Q50602478 | ||
| Psychological consequences of presymptomatic testing for Huntington's disease. | Q51105009 | ||
| Anxiety and depression in patients with chest pain referred for exercise testing. | Q51219357 | ||
| Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. | Q52910608 | ||
| Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. | Q53206312 | ||
| Understanding responses to predictive genetic testing: A grounded theory approach | Q57745677 | ||
| P433 | issue | 1 | |
| P921 | main subject | questionnaire | Q747810 |
| P304 | page(s) | 62-74 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | American Journal of Medical Genetics Part A | Q15755121 |
| P1476 | title | Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup | |
| P478 | volume | 75 |
| Q37323166 | A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases |
| Q39438268 | Adults seeking presymptomatic gene testing for Huntington disease |
| Q51651054 | American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. |
| Q35433653 | An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling |
| Q35915959 | Analysis of pre-test interviews in a cohort of Brazilian patients with movement disorders |
| Q35571101 | Carrier testing of children for two X linked diseases in a family based setting: a retrospective long term psychosocial evaluation |
| Q46963399 | Case Report: Depression vs. Early-Onset Alzheimer Disease: The Genetic Counselor's Role |
| Q80801043 | Distress and family functioning in oncogenetic counselling for hereditary and familial breast and/or ovarian cancers |
| Q40601561 | Ethical dilemmas in testing for late onset conditions: reactions to testing and perceived impact on other family members |
| Q34144333 | Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling |
| Q36098629 | Familial adenomatous polyposis in an adolescent with coexisting schizophrenia: treatment strategies and implications |
| Q38833267 | Genetic counseling and testing for Huntington's disease: A historical review |
| Q56508854 | Genetic counseling in hereditary breast/ovarian cancer in Israel: Psychosocial impact and retention of genetic information |
| Q90005056 | Improving follow up after predictive testing in Huntington's disease: evaluating a genetic counselling narrative group session |
| Q36160904 | Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers |
| Q81288350 | Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure |
| Q53487404 | Protecting genetic privacy. |
| Q40413772 | Psychodynamic theory and counseling in predictive testing for Huntington's disease |
| Q35553864 | Psychosocial Issues Associated with Genetic Testing for Breast and Ovarian Cancer Risk: An Integrative Review |
| Q35133986 | Safeguarding being: a bioethical principle for genetic nursing care |
| Q36687673 | Should we genetically test everyone for haemochromatosis? |
| Q39468964 | The impact of having a sister diagnosed with breast cancer on cancer-related distress and breast cancer risk perception |
| Q45292992 | The psychological dimension of informed consent: dissonance processes in genetic testing |
Search more.